1. The role of genetics in coronary artery bypass surgery patients under 30 years of age.
- Author
-
Sarikaya S, Aydin E, Ozen Y, Ozer T, Kirali K, and Rabus MB
- Subjects
- Adult, Age of Onset, Comorbidity, Coronary Artery Disease diagnosis, Coronary Artery Disease physiopathology, DNA Mutational Analysis, Female, Genetic Predisposition to Disease, Heterozygote, Homozygote, Humans, Male, Phenotype, Retrospective Studies, Risk Factors, Stroke Volume, Ventricular Function, Left, Young Adult, Coronary Artery Bypass, Coronary Artery Disease genetics, Coronary Artery Disease surgery, Integrin beta3 genetics, Methylenetetrahydrofolate Reductase (NADPH2) genetics, Mutation, Plasminogen Activator Inhibitor 1 genetics, Polymorphism, Genetic
- Abstract
Aim: We undertook genetic assessment of coronary artery disease (CAD) in 20 patients aged 30 years or less undergoing coronary artery bypass grafting (CABG) surgery, to investigate the prognostic value of pre-defined genes., Methods: Twenty patients, who underwent CABG surgery between December 2001 and May 2013, were retrospectively analysed to find out the role their genetic make-up played in their disease. We used three genetic diagnostic tests, the plasminogen activator inhibitor (PAI) -1 gene, the A1/A2 polymorphism of glycoprotein IIIa (GpIIIa) gene, and common polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene., Results: The mean age of patients was 26.35 ± 3.51 (19-30) years, and 90% were male (n = 18). One patient had diabetes, three had hypertension, 11 (55%) had dyslipidaemia and 16 (80%) were smokers. Eight of the patients (40%) had left ventricular ejection fraction (LVEF) < 50%, and functional capacity was poor in only two (10%) patients (NYHA III-IV). Follow up was completed in all patients (100%). We found five homozygous and 11 heterozygous mutations in the MTHFR gene, which predisposes individuals to coronary artery disease or deep-vein thrombosis. Eight patients were found to have a GpIIIa gene polymorphism, which is associated with increased risk of myocardial infarction (MI). Fifteen patients had a polymorphism in the promoter region of the PAI-1 gene, which is a major inhibitor of the fibrinolytic system., Conclusion: MTHFR C677T polymorphism, and GpIIIa and PAI-1 genes are risk factors for CAD. In young patients, genetic studies promise to revolutionise early diagnosis, treatment and prevention of CAD and MI.
- Published
- 2017
- Full Text
- View/download PDF